Sort
39,280 grants matching “leukemia”
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
$1,431,382Russell E Ware · Cincinnati Childrens Hosp Med Ctr · U01 · FY2023 · HL
DCTD Cancer Diagnosis
$1,429,690David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,428,684Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Data Scientific Research
$1,428,663David H Haussler · University Of California Santa Cruz · U54 · FY2014 · HG
Studies of Populations Exposed to Diagnostic Medical Radiation
$1,427,605Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Receptor-directed Therapy
$1,426,655John Janik · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Hematopoietic stem cell commitment
$1,425,685Daniel G Tenen · Beth Israel Deaconess Medical Center · P01 · FY2008 · DK
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
$1,424,426Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2019 · HL
Delaware/Christiana Care Community Clinical Oncology Program
$1,423,934Stephen S. Grubbs · Christiana Care Health Services, Inc. · U10 · FY2012 · CA
Hematopoietic stem cell commitment
$1,423,863Daniel G Tenen · Beth Israel Deaconess Medical Center · P01 · FY2011 · DK
Realizing Effectiveness Across Continents with Hydroxyurea(REACH): A Phase I/II Pilot Study of Hyroxyurea for Children with Sickle Cell Anemia
$1,423,588Russell E Ware · Cincinnati Childrens Hosp Med Ctr · U01 · FY2024 · HL
Cytokines and T Cell Development
$1,423,160Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant
$1,421,697Michael E. Roth · Public Health Institute · UG1 · FY2024 · CA
Improving Retroviral Vectors for Gene Delivery
$1,420,568University Of Southern California · P01 · FY2002 · CA
Tobacco Carcinogenesis and Chemoprevention
$1,419,959Institute For Cancer Prevention · P01 · FY2003 · CA
Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector
$1,418,589Sung-Yun Pai · Boston Children'S Hospital · U01 · FY2018 · AI
Discovery of Anticancer Agents of Diverse Natural Origin
$1,417,476Alan Douglas Kinghorn · Ohio State University · P01 · FY2015 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,416,959Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Hematopoietic stem cell (HSC) genetic and cellular therapies
$1,416,882Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,416,172Julie R Park · Seattle Children'S Hospital · U01 · FY2019 · TR
DEFINING LEUKEMIA STEM CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
$1,416,000Children'S Hospital Corporation, The · · FY2021 · Department of the Army
Risk Factors for Aged Related Bone Loss
$1,415,547Douglas P. Kiel · Hebrew Rehabilitation Center For Aged · R01 · FY2011 · AR
Flow Cytometric Analysis of Benign and Malignant Tumors
$1,414,990Maryalice Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIC · FY2011 · CA
ECHO Renewal for the CANOE Study Cohort
$1,414,688Tina V Hartert · Vanderbilt University Medical Center · UG3 · FY2024 · OD
Molecular Determinants of Cancer Therapeutic Response
$1,414,467Raymond J Monnat · University Of Washington · P01 · FY2019 · CA